14,038 Shares in The Clorox Company $CLX Bought by Titan Investment Management LLC

Titan Investment Management LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 14,038 shares of the company’s stock, valued at approximately $1,415,000.

Several other hedge funds have also bought and sold shares of CLX. Norges Bank purchased a new stake in Clorox in the fourth quarter worth about $135,735,000. Van ECK Associates Corp boosted its position in shares of Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Invesco Ltd. boosted its position in shares of Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Clorox by 6,907.9% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock worth $75,593,000 after buying an additional 739,005 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new stake in shares of Clorox in the 2nd quarter worth approximately $71,856,000. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.0%

Clorox stock opened at $95.90 on Friday. The stock has a market cap of $11.60 billion, a P/E ratio of 15.57, a PEG ratio of 0.49 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The firm’s 50 day moving average price is $95.91 and its 200-day moving average price is $104.88.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $1.45 earnings per share. Clorox’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities analysts predict that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research analyst reports. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Wells Fargo & Company cut their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a report on Monday, May 18th. Evercore reiterated an “underperform” rating and set a $110.00 price objective on shares of Clorox in a research report on Friday, May 1st. Morgan Stanley lowered their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Finally, Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.